Crosslinking of α-synuclein by advanced glycation endproducts -: an early pathophysiological step in Lewy body formation?

被引:182
作者
Münch, G
Lüth, HJ
Wong, A
Arendt, T
Hirsch, E
Ravid, R
Riederer, P [1 ]
机构
[1] Univ Wurzburg, Sch Med, Dept Psychiat, Wurzburg, Germany
[2] Netherlands Brain Bank, Amsterdam, Netherlands
[3] Hop La Pitie Salpetriere, INSERM U289, Paris, France
[4] Univ Leipzig, Paul Flechsig Inst Hindforsch, Leipzig, Germany
[5] Univ Leipzig, Interdisciplinary Ctr Clin Res, Neuroimmunol Cell Biol Grp, D-7010 Leipzig, Germany
关键词
Lewy bodies; Parkinson's disease; neurodegeneration; advanced glycation endproducts; oxidative stress;
D O I
10.1016/S0891-0618(00)00096-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An excess of reactive carbonyl compounds (carbonyl stress) and their reaction products, advanced glycation endproducts (AGEs), are thought to play a decisive role in the pathogenesis of neurodegenerative disorders and Parkinson's disease (PD) in particular. Accumulation of AGEs in various intracellular pathological hallmarks of PD. such as Lewy bodies, densely crosslinked intracellular protein deposits formed from neurofilament components and alpha -synuclein, have already been described in patients in advanced stages of the disease. There is, however, no indication of the involvement of AGE-induced crosslinking of alpha -synuclein in very early stages of the disease. In this study, we observed that AGEs and alpha -synuclein are similarly distributed in very early Lewy bodies in the human brain in cases with incidental Lewy body disease. These cases might be viewed as pre-Parkinson patients, i.e. patients who came for autopsy before the possible development of clinical signs of PD. AGEs are both markers of transition metal induced oxidative stress as well as, inducers of protein crosslinking and free radical formation by chemical and cellular processes. Thus, it is likely that AGE promoted formation of Lewy bodies reflects very early causative changes rather than late epiphenomenons of PD. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:253 / 257
页数:5
相关论文
共 26 条
  • [1] Braak H, 1995, J NEURAL TRANSM-SUPP, P15
  • [2] Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
    Castellani, R
    Smith, MA
    Richey, PL
    Perry, G
    [J]. BRAIN RESEARCH, 1996, 737 (1-2) : 195 - 200
  • [3] Sequestration of iron by Lewy bodies in Parkinson's disease
    Castellani, RJ
    Siedlak, SL
    Perry, G
    Smith, MA
    [J]. ACTA NEUROPATHOLOGICA, 2000, 100 (02) : 111 - 114
  • [4] α-Synuclein immunoreactivity in dementia with Lewy bodies:: morphological staging and comparison with ubiquitin immunostaining
    Gómez-Tortosa, E
    Newell, K
    Irizarry, MC
    Sanders, JL
    Hyman, BT
    [J]. ACTA NEUROPATHOLOGICA, 2000, 99 (04) : 352 - 357
  • [5] Understanding cell death in Parkinson's disease
    Jenner, P
    Olanow, CW
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : S72 - S84
  • [6] Amadorins: Novel post-Amadori inhibitors of advanced glycation reactions
    Khalifah, RG
    Baynes, JW
    Hudson, BG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (02) : 251 - 258
  • [7] Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
    Krüger, R
    Müller, T
    Riess, O
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (01) : 31 - 40
  • [8] LOSKE C, 2000, EUR J BIOCHEM, P1
  • [9] INTERLEUKIN-1-BETA, INTERLEUKIN-6, EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA ARE ELEVATED IN THE BRAIN FROM PARKINSONIAN-PATIENTS
    MOGI, M
    HARADA, M
    KONDO, T
    RIEDERER, P
    INAGAKI, H
    MINAMI, M
    NAGATSU, T
    [J]. NEUROSCIENCE LETTERS, 1994, 180 (02) : 147 - 150
  • [10] TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) INCREASES BOTH IN THE BRAIN AND IN THE CEREBROSPINAL-FLUID FROM PARKINSONIAN-PATIENTS
    MOGI, M
    HARADA, M
    RIEDERER, P
    NARABAYASHI, H
    FUJITA, K
    NAGATSU, T
    [J]. NEUROSCIENCE LETTERS, 1994, 165 (1-2) : 208 - 210